Jinxin Fertility Group Ltd (1951.HK) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN KYG5140J1013
Jinxin Fertility Group Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.81 bn CNY | 2.65 bn CNY |
| Gross profit | 1.10 bn CNY | 840.01 m CNY |
| EBIT | 441.00 m CNY | 202.94 m CNY |
| Net income | 283.00 m CNY | -975.90 m CNY |
| Diluted EPS – continuing operations | 0.10 CNY | -0.49 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jinxin Fertility Group Ltd
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and internationally. The company provides two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it provides pre-implantation genetic screening testing, management consultancy, postpartum and rehabilitation care, maternal-child nursing, and other hospital- derived services. Additionally, the company is involved in property investment, and real estate development and operation activities; sale of medicines, consumables, and equipment; research and development of IVF related projects, including scientific research and related commercialization; and operates restaurant. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.
More stocks
- COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Nextdoor Holdings, Inc. (NXDR)
- KRONOS WORLDWIDE INC (KRO)
- Corvus Pharmaceuticals, Inc. (CRVS)
- Riley Exploration Permian, Inc. (REPX)
- Sinostone Guangdong Co Ltd (001212.SZ)
- Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC (CCN.PA)
- SK Networks Co Ltd (001740.KS)
- Voyager Technologies, Inc./TX (VOYG)
- MeiraGTx Holdings plc (MGTX)
- Jutze Intelligent Technology Co Ltd (300802.SZ)
- ASTEC INDUSTRIES INC (ASTE)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.